All News

Identifying the particular genes at play in multiple sclerosis (MS) could lead to a better understanding of the disease, and possibly better therapies for it. A new paper proposes network representation learning as the best method to identify those genes.

When should a child with asthma be considered for biologic therapy? It's important to get the basics right first, argues the author of a recent paper.

Some oncologists refrain from prescribing checkpoint immunotherapy in patients with Kaposi sarcoma who also have psoriasis or other skin conditions. A new case report says the therapy can be successfully completed while still controlling the skin condition.

It’s rare for a patient to be diagnosed with both acute myeloid leukemia and multiple myeloma at the same time, but a new case study suggests there are options to treat both diseases at the same time in such cases.

Biosimilar developers can assuage some physician—and even patient—concerns through coordinated, evidence-based messaging.

A recent study describes the use of a liquid assay to uncover any links between response to treatment and tumor load score in patients with stage 2 or stage 3 cancer with solid tumors. Circulating tumor DNA is linked with more advanced cancer.

Female survivors of breast cancer total over 3.5 million in the United States alone. Coronary heart disease is a leading cause of death among this patient group, as it is for all women.

The cost of giving birth in the United States can vary by thousands of dollars depending on where the birth takes place. In Arkansas, inpatient birth charges come out to roughly $8300, but that total rises to nearly $20,000 in New York.

The worldwide fatality rate from coronavirus disease 2019 (COVID-19) now exceeds 7%, and more than 3 million cases have been reported. Cardiovascular disease is a well-known factor for increasing the risk of contracting this sometimes deadly virus.

In light of the coronavirus disease 2019 (COVID-19) pandemic, pharmacies have implemented new strategies to ensure their patients continue to receive care, especially for those who have lost their insurance or have underlying conditions, speakers said this week during the Pharmacy Quality Alliance (PQA) 2020 Annual Meeting.

Platelet function may aid in determining disease severity for patients with psoriasis who are at an increased risk of developing cardiovascular disease (CVD) and increased inflammation, a review notes.

Quality, as opposed to duration, was suggested as the optimal target for prevention and intervention in sleep health among adolescents, with potential efficacy cited in improving psychological functioning, according to study findings.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

President Trump will restructure the Strategic National Stockpile and increase America's production of supplies; the National Institutes of Health (NIH) is testing a new combination therapy for coronavirus disease 2019; FDA officials issue warning on Abbott Laboratories' rapid response test.

Patients who are treated with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia are at a higher risk of a secondary malignancy. A new case study suggest the list of potential secondary malignancies should include lymphoplasmacytic lymphoma.

Maureen is senior vice president, director of Value Transformation for PRECISIONvalue. Maureen has extensive experience as a C-level executive, clinician, academician, innovator, and coach in managed, integrated care. Nationally, she has developed innovative products and strategies for industry executives and access decision makers. Under her leadership, organizations have received recognition from eValue8, NCQA, and the National Academy of Medicine for innovative strategies that have reduced hospital readmissions, improved patient safety, and enhanced patient engagement. Since joining Precision, she has led more than 500 strategic quality and population health initiatives with 35 clients in 17 therapeutic areas. Her expertise includes adherence, behavioral health/social wellness, crisis management, patient engagement, population health, quality, social determinants of health, and value-based care.

A new study based on interviews with families and patients undergoing chronic transfusion therapy for sickle cell disease finds that the therapy affects the families in ways that extend beyond health.

This week, the top managed care news included testimony on the response to the COVID-19 pandemic; a rare inflammatory disease emerging in children with COVID-19; a novel cell replacement treatment shows promise in Parkinson disease.

Washington is home to 2 pertinent developments in the arrival of coronavirus disease 2019 (COVID-19) to the United States: the first US case of the virus was reported in the state on January 21 and the first major US city to report deaths as a result was Seattle.

Teenagers with obesity, type 2 diabetes (T2D), or high blood pressure may have a higher risk of experiencing premature vascular aging compared with teens without the conditions, according to a study published in the Journal of the American Heart Association.

The investigators made a presumptive diagnosis of acute interstitial pneumonia after the patient presented with fever, chills, muscle pain and a dry cough, which deteriorated into respiratory failure, soon after the woman ran a half marathon.

A new analysis of patients with early multiple sclerosis (MS) suggests they universally carry antibodies for Epstein-Barr virus, a virus increasingly thought to be linked to MS.

Visual impairment (VI) is estimated to affect around 1 in 11 US adults aged 65 and older and is associated with an increased risk of falls, social isolation, loss of independence, disability, and dementia. Older adults with dementia and self-reported VI may be at high risk for disability, while the co-occurrence of the 2 conditions may potentiate this risk, according to a study published in JAMA Ophthalmology.

Uncertainty remains surrounding the overall cost of care for employers, as subsequent waves of coronavirus disease 2019 (COVID-19)–related care may occur. Current projections suggest a lower health care spend due to deferral of nonrelated care, said Trevis Parson, chief actuary of Health & Benefits North America at Willis Towers Watson.

French pharmaceutical company Sanofi will expand access to a potential coronavirus disease 2019 (COVID-19) vaccine among Europeans; COVID-19 outbreaks in prisons threaten already-strained rural hospitals; individuals with chronic illnesses report alcohol intake exceeding recommended guidelines.

Reports of children contracting—and occasionally dying—from a rare inflammatory disorder associated with coronavirus disease 2019 (COVID-19) have prompted concern, as the disease has so far largely spared pediatric populations. But a new study from Italy indicates that the disorder associated with COVID-19 is more severe than the type known before the pandemic.

Insufficient response to triptans is associated with poor health-related quality of life and lower work productivity in migraineurs compared with those who respond well to the medications, according to a study published in The Journal of Headache and Pain.

Patients hospitalized due to acute decompensated heart failure have both a higher rate of annual mortality, compared with patients who have chronic ambulatory heart failure, and of dying within 6 months of hospital release.